Brown J - Search Results

1

GR196429: a nonindolic agonist at high-affinity melatonin receptors.

Beresford IJ, Browning C, Starkey SJ, Brown J, Foord SM, Coughlan J, North PC, Dubocovich ML, Hagan RM. Beresford IJ, et al. Among authors: brown j. J Pharmacol Exp Ther. 1998 Jun;285(3):1239-45. J Pharmacol Exp Ther. 1998. PMID: 9618428

2

The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor.

Fraser NJ, Wise A, Brown J, McLatchie LM, Main MJ, Foord SM. Fraser NJ, et al. Among authors: brown j. Mol Pharmacol. 1999 Jun;55(6):1054-9. doi: 10.1124/mol.55.6.1054. Mol Pharmacol. 1999. PMID: 10347248

3

The CGRP receptor can couple via pertussis toxin sensitive and insensitive G proteins.

Main MJ, Brown J, Brown S, Fraser NJ, Foord SM. Main MJ, et al. Among authors: brown s, brown j. FEBS Lett. 1998 Dec 11;441(1):6-10. doi: 10.1016/s0014-5793(98)01507-5. FEBS Lett. 1998. PMID: 9877154 Free article.

4

The N-terminus of RAMPs is a critical determinant of the glycosylation state and ligand binding of calcitonin receptor-like receptor.

Foord SM, Wise A, Brown J, Main MJ, Fraser NJ. Foord SM, et al. Among authors: brown j. Biochem Soc Trans. 1999 Aug;27(4):535-9. doi: 10.1042/bst0270535. Biochem Soc Trans. 1999. PMID: 10917636 Review. No abstract available.

5

RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.

McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM. McLatchie LM, et al. Among authors: brown j. Nature. 1998 May 28;393(6683):333-9. doi: 10.1038/30666. Nature. 1998. PMID: 9620797

6

Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.

Brown AJ, Daniels DA, Kassim M, Brown S, Haslam CP, Terrell VR, Brown J, Nichols PL, Staton PC, Wise A, Dowell SJ. Brown AJ, et al. Among authors: brown s, brown j. J Pharmacol Exp Ther. 2011 Apr;337(1):236-46. doi: 10.1124/jpet.110.172650. Epub 2011 Jan 13. J Pharmacol Exp Ther. 2011. PMID: 21233197

7

Pharmacological activity of VUF 9153, an isothiourea histamine H3 receptor antagonist.

Barnes JC, Brown JD, Clarke NP, Clapham J, Evans DJ, O'Shaughnessy CT. Barnes JC, et al. Among authors: brown jd. Eur J Pharmacol. 1993 Nov 30;250(1):147-52. doi: 10.1016/0014-2999(93)90632-r. Eur J Pharmacol. 1993. PMID: 8119312

8

Characterisation of the specific binding of the histamine H3 receptor antagonist radioligand [3H]GR168320.

Brown JD, O'Shaughnessy CT, Kilpatrick GJ, Scopes DI, Beswick P, Clitherow JW, Barnes JC. Brown JD, et al. Eur J Pharmacol. 1996 Sep 12;311(2-3):305-10. doi: 10.1016/0014-2999(96)00428-1. Eur J Pharmacol. 1996. PMID: 8891613

9

Use of a dual firefly and Renilla luciferase reporter gene assay to simultaneously determine drug selectivity at human corticotrophin releasing hormone 1 and 2 receptors.

Parsons SJ, Rhodes SA, Connor HE, Rees S, Brown J, Giles H. Parsons SJ, et al. Among authors: brown j. Anal Biochem. 2000 Jun 1;281(2):187-92. doi: 10.1006/abio.2000.4570. Anal Biochem. 2000. PMID: 10870834

10

5-hydroxyindalpine, an agonist at the putative 5-HT receptor, has no activity on human recombinant monoamine receptors but accelerates distension-induced peristalsis in mouse isolated colon.

Mitchell NA, Pepperell E, Ociepka S, Brown JD, Witherington J, Tuladhar B, Sanger GJ, Lee K, Cellek S. Mitchell NA, et al. Among authors: brown jd. Neurogastroenterol Motil. 2009 Jul;21(7):760-e48. doi: 10.1111/j.1365-2982.2009.01275.x. Epub 2009 Mar 2. Neurogastroenterol Motil. 2009. PMID: 19309442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,034 results

Search Page

Filters